FFilingSight

Not investment advice. FilingSight is an automated analytical research tool, not a registered investment advisor. Ratings and scores are quantitative analytical classifications, not buy or sell recommendations. Nothing here is personalized to your circumstances. Investing involves risk of loss — consult a licensed professional. See full disclosures.

Create a free account to read 3 full reports each month — plus a 14-day Pro trial. Get started →

Morgan Stanley

MSFinancials

Generated Jul 5, 2026, 08:51 PM UTC

analytical score -13

MS (Morgan Stanley) analytical snapshot. Return on equity 8.69%, ROA 0.75%, ROIC 0.00%. Net income down ▼ +17.6% YoY. Debt/equity 3.18, current ratio —, net debt $229.48B. Market cap $337.43B at $213.93 per share. Trailing P/E 41.30, P/S 12.89, P/B 2.95. EV/Operating income ≈ 4108.04 (EV $566.91B). Risk: High. Macro: Risk-on · Supportive. Composite analytical score -13 (data confidence 74%). Descriptive analytics from public filings — not investment advice.

Market cap
$337.43B
1.58B shares
Price
$213.93
NYQ
P/E (ttm)
41.30
Revenue (FY)
Net margin
Free cash flow
Risk level
High

Free SEC analysis

— computed from SEC filings, free to read
Free previewFundamentals Analyst

Fundamentals

Fundamentals Analyst
score -20Deteriorating
60% conf

Return on equity 8.69%, ROA 0.75%, ROIC 0.00%. Net income down ▼ +17.6% YoY. Debt/equity 3.18, current ratio —, net debt $229.48B.

  • Return on equity 8.69%, ROA 0.75%, ROIC 0.00%.
  • Net income down ▼ +17.6% YoY.
  • Debt/equity 3.18, current ratio —, net debt $229.48B.
Revenue (FY)
Net margin
ROE
8.69%
ROA 0.75%
ROIC
0.00%
EPS (diluted)
$5.18
FY2025
Free cash flow
Debt / equity
3.18
Cash $133.53B
Current ratio
Equity $114.29B
Annual fundamentals — up to 10 years (SEC 10-K, US-GAAP)
FYRevenueRev YoYGross%Op%Net%FCFROE%
20164.61
20178.06
20187.73
20197.62
202010.73
20218.88
202210.43
202315.01
202411.14
20258.69
Quarterly revenue trend (last 6 quarters, SEC 10-Q)
Quarter endRevenueYoYQoQNet margin
Jun 30, 2014$8.61B-48.3%39.54%
Sep 30, 2014$26.51B+7.8%+208.0%19.23%
Sep 30, 2014$8.91B-63.8%-66.4%57.22%
Mar 31, 2015$9.91B+11.0%+11.2%24.16%
Jun 30, 2015$19.65B+11.9%+98.3%21.38%
Jun 30, 2015$9.74B-44.5%-50.4%43.12%
Free previewRegulatory Analyst

Filings & Ownership

Regulatory Analyst
score 25Improving
80% conf

Recent insider Form 4s: 0 buy vs 0 sell transactions. ~10,000+ recent 13F-HR filings reference Morgan Stanley; broad institutional reporting. Recent filers include Washington Trust Advisors, Inc., Washington Trust Advisors, Inc., Washington Trust Advisors, Inc..

  • Recent insider Form 4s: 0 buy vs 0 sell transactions.
  • ~10,000+ recent 13F-HR filings reference Morgan Stanley; broad institutional reporting.
  • Recent filers include Washington Trust Advisors, Inc., Washington Trust Advisors, Inc., Washington Trust Advisors, Inc..
  • 11 recent 13D activist/beneficial-ownership filings — potential catalyst.
  • 9 recent 13G passive institutional ownership notices.
Latest 10-K
Latest 10-Q
8-K (recent)
0
Insider net
0B/0S
13F filers
10k+
Activist 13D
11
Recent 13F institutional filers (SEC EDGAR full-text)
FilerFormFiled
Washington Trust Advisors, Inc.13F-HRMay 11, 2023
Washington Trust Advisors, Inc.13F-HRJul 27, 2023
Washington Trust Advisors, Inc.13F-HRJan 18, 2024
Washington Trust Advisors, Inc.13F-HRMay 7, 2024
Washington Trust Advisors, Inc.13F-HRJul 25, 2024
Free previewSEC Filing Analyst

SEC Filing Deep-Analysis

SEC Filing Analyst
score -72Deteriorating
62% conf

5 risk signal(s), 1 watch item(s) detected from XBRL filing diff analysis. Revenue grew -18.8% but receivables grew -3.6% — the receivables-to-revenue gap suggests growth may be partially driven by extended credit terms rather than genuine demand. If DSO continues to rise, a revenue reversal or bad-debt charge could follow.

  • Receivables outpacing revenue: Accounts receivable grew -3.6% YoY vs revenue growth of -18.8%. The +15.1% spread suggests extended credit terms, channel stuffing risk, or collection deterioration. Investigate the allowance for doubtful accounts and DSO trend.
  • Going concern doubt: The term "going concern" appears in 77 recent filing(s) (vs 8 in the prior period). This risk language is ongoing.
  • Material weakness in internal controls: The term "material weakness" appears in 19 recent filing(s) (vs 2 in the prior period). This risk language is ongoing.
  • NEW: Substantial doubt about ability to continue in latest filing: The term "substantial doubt" "ability to continue" appears in recent 10-K/10-Q filings but was NOT present in the prior 24-month period. This is a new risk disclosure that warrants attention. Found in 5 filing(s).
  • NEW: Restatement of financial statements in latest filing: The term "restate" "financial statements" appears in recent 10-K/10-Q filings but was NOT present in the prior 24-month period. This is a new risk disclosure that warrants attention. Found in 9 filing(s).
  • NEW: Impairment charge: Impairment charge appears in recent filings but not in the prior 24-month period. Monitor for materiality.
  • Endogenous analysis: Revenue grew -18.8% but receivables grew -3.6% — the receivables-to-revenue gap suggests growth may be partially driven by extended credit terms rather than genuine demand. If DSO continues to rise, a revenue reversal or bad-debt charge could follow.
  • 20 disclosure(s) dropped from prior year — reduced reporting granularity.
  • 3 new risk-language term(s) detected in filing text: Substantial doubt about ability to continue, Restatement of financial statements, Impairment charge.
  • Ongoing high-severity risk language: Going concern doubt, Material weakness in internal controls.
Revenue
$26.18B
-18.8% YoY
Operating income
$138.0M
-96.7% YoY
Net income
$9.09B
-17.6% YoY
Operating cash flow
$-33.54B
-424.2% YoY
Total assets
$1.22T
+1.8% YoY
Total liabilities
$1.11T
+1.5% YoY
Long-term debt
$284.31B
+9.1% YoY
Cash & equivalents
$105.39B
+18.1% YoY
Filing quality score
70/100
stable
SEC XBRL metric changes (latest annual vs prior)
MetricPrior yearLatest yearChange% Change
Revenue$32.23B$26.18B$-6.05B-18.8%
Operating income$4.17B$138.0M$-4.03B-96.7%
Net income$11.03B$9.09B$-1.94B-17.6%
Operating cash flow$-6.40B$-33.54B$-27.14B-424.2%
Total assets$1.19T$1.22T$21.38B+1.8%
Total liabilities$1.09T$1.11T$15.93B+1.5%
Long-term debt$260.54B$284.31B$23.76B+9.1%
Cash & equivalents$89.23B$105.39B$16.15B+18.1%
Stockholders equity$99.04B$104.51B$5.47B+5.5%
Accounts receivable$35.26B$33.98B$-1.28B-3.6%
Interest expense$3.85B$1.37B$-2.48B-64.5%
XBRL disclosure changes (new vs dropped concepts)
TypeConcepts
RemovedAccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax, AllocatedShareBasedCompensationExpense, AmortizationOfIntangibleAssets, AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries, CurrentFederalTaxExpenseBenefit, CurrentForeignTaxExpenseBenefit, CurrentIncomeTaxExpenseBenefit, CurrentStateAndLocalTaxExpenseBenefit, DeferredCompensationArrangementWithIndividualCompensationExpense, DeferredFederalIncomeTaxExpenseBenefit
Risk language in filing text (EDGAR full-text search)
TermSeverityRecentPriorStatus
Going concern doubthigh778Ongoing
Material weakness in internal controlshigh192Ongoing
Substantial doubt about ability to continuehigh50NEW
Restatement of financial statementshigh90NEW
Impairment chargemedium410NEW
Restructuringmedium1248Ongoing
Off-balance sheet arrangementsmedium1098Ongoing
Related party transactionslow40NEW
Filing signal breakdown
Red flags: 5
Positive: 0
Watch: 1
Red flags
Positive
Watch

Unlock the rest

  • Valuation
    Market cap $337.43B at $213.93 per share.
    Pro
  • Price & Technicals
    Price $213.93 — uptrend (above 200-DMA); 1-month momentum negative.
    Pro
  • Macro & Rates
    Market regime: Risk-on · Supportive.
    Pro
  • Risk Scorecard
    Composite risk: High.
    Pro

This content is for Pro subscribers

Unlock the full breakdown from all analysts — valuation (DCF & Graham), price & technicals, macro, risk scorecard, and 13F/13D ownership flow — plus your research workspace.

3 sections free · 4 Pro sections locked · composite -13

Macro exposure

Rate-sensitive · High sensitivity
Neutral

Macro regime: Risk-on · Supportive. Morgan Stanley is a rate-sensitive name (high macro sensitivity) — a supportive backdrop, though defensives lag risk-on tapes.

Macro regime
Risk-on · Supportive
Yield curve
Normal
VIX
16.59
Fed funds
3.63%
CPI YoY
+4.2%

Analytical read

deterministic preview

Price $213.93 — uptrend (above 200-DMA); 1-month momentum negative..

Risk
High
Macro regime
Risk-on · Supportive
Macro exposure
Neutral
Descriptive analytics from public filings and macro data — not investment advice.

Peer comparison

Rate-sensitive group

How MS stacks up against tracked peers with similar macro sensitivity — by analytical score and macro exposure.

CompanyScoreMacro
Capital One Financial COF23Neutral
Chubb Ltd. CB23Neutral
U.S. Bancorp USB17Neutral
JPMorgan Chase & Co. JPM16Neutral
Prologis Inc. PLD14Neutral
Simon Property Group SPG13Neutral
American Express Co. AXP11Neutral
Bank of America Corp. BAC11Neutral
Visa Inc. V8Neutral
Mastercard Inc. MA8Neutral
Public Storage PSA8Neutral
Dominion Energy D6Neutral
Charles Schwab Corp. SCHW6Neutral
CME Group Inc. CME6Neutral
PNC Financial Services PNC4Neutral
Realty Income Corp. O4Neutral
Travelers Cos. TRV2Neutral
NextEra Energy NEE0Neutral
Duke Energy Corp. DUK0Neutral
Bank of New York Mellon BK0Neutral
Marsh & McLennan MMC0Neutral
Equity Residential EQR0Neutral
Wells Fargo & Co. WFC-1Neutral
Welltower Inc. WELL-1Neutral
Exelon Corp. EXC-3Neutral
Xcel Energy XEL-5Neutral
American International Group AIG-5Neutral
Digital Realty Trust DLR-6Neutral
Allstate Corp. ALL-7Neutral
S&P Global SPGI-8Neutral
American Water Works AWK-9Neutral
Goldman Sachs Group GS-10Neutral
Citigroup Inc. C-11Neutral
Moody's Corp. MCO-13Neutral
Morgan Stanley MS● you-13Neutral
MetLife Inc. MET-13Neutral
BlackRock Inc. BLK-15Neutral
Equinix Inc. EQIX-16Neutral
American Electric Power AEP-18Neutral
Crown Castle Inc. CCI-18Neutral
American Tower Corp. AMT-35Neutral
Southern Company SONeutral
Truist Financial TFCNeutral